Drugs / trivalent oral polio vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02477046 | Apr 2015 → Jul 2016 | — | University of Virginia | Unknown | Missed primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | trivalent oral polio vaccine | “Trivalent oral polio vaccine (tOPV) was replaced worldwide” PMID 28693854 ↗ Jul 2017 |
| Known as | tOPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02477046 ↗ |
| Modality | Vaccine | “Trivalent oral polio vaccine (tOPV)” NCT02477046 ↗ |
| Route | Oral | “Trivalent oral polio vaccine (tOPV)” NCT02477046 ↗ |